As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...

This article and associated images are based on a poster originally authored by Marina Fedorova and Ian Hiles and presented at ELRIG Drug Discovery 2024 in affiliation with GSK. This poster is being ...

Streamlined, automation-ready approaches help scientists reproducibly generate antibody data with high-yield HEK293 transient ...

The market presents significant opportunities driven by high demand for biologics and protein therapeutics, as well as ...